Cipher Pharmaceuticals Company Profile (NASDAQ:CPHR)

About Cipher Pharmaceuticals

Cipher Pharmaceuticals logoCipher Pharmaceuticals Inc. is a specialty pharmaceutical dermatology company. The Company has a portfolio of commercial and late-stage products. It operates in the specialty pharmaceuticals segment. It acquires products and compounds for treatment of various medical needs. Its commercial product portfolio includes ABSORICA; SITAVIG; NUVAIL; BIONECT; CLN8; INOVA; PRO:12 MOUSSE; AL12; LOTION UMECTA; ACLARO; EPURIS; VANIQA; ACTIKERALL; BETEFLAM; LIPOFEN; CONZIP, and DURELA. Its products treat indications, such as severe nodular acne, recurrent herpes labialis, nail dystrophy, dermal ulcers, mild/moderate onychomycosis, acne, dry skin, keratosis, hyperpigmentation, hyperkeratotic actinic keratosis and high cholesterol. Its pipeline of late-stage products includes DERMADEXIN, BETEFLAM PATCH, SITAVIG, PRURIDEXIN, OZENOXACIN, CF101 for plaque psoriasis, CF101 for rheumatoid arthritis, ASF-1096 and NANOLIPOLEE-007. It operates in Canada and the United States.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CPHR
  • CUSIP:
Key Metrics:
  • Previous Close: $3.89
  • 50 Day Moving Average: $4.89
  • 200 Day Moving Average: $5.18
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 16.91
  • P/E Growth: 0.00
  • Market Cap: $101.90M
  • Outstanding Shares: 26,195,000
  • Beta: 1.74
Additional Links:
Companies Related to Cipher Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Cipher Pharmaceuticals (NASDAQ:CPHR) (?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $6.85 (76.09% upside)

Analysts' Ratings History for Cipher Pharmaceuticals (NASDAQ:CPHR)
Show:
DateFirmActionRatingPrice TargetDetails
8/13/2016TD SecuritiesReiterated RatingBuy$7.50View Rating Details
8/13/2016GMP SecuritiesReiterated RatingHoldView Rating Details
11/30/2015CIBCInitiated CoverageSector Outperform -> Outperform$6.20View Rating Details
(Data available from 8/27/2014 forward)

Earnings

Earnings History for Cipher Pharmaceuticals (NASDAQ:CPHR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/4/2015$0.07($0.04)ViewN/AView Earnings Details
8/14/2015$0.02$0.01ViewN/AView Earnings Details
5/13/2015Q115$0.17$0.10$7.88 million$9.18 millionViewN/AView Earnings Details
2/25/2015$0.12$0.12ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cipher Pharmaceuticals (NASDAQ:CPHR)
Current Year EPS Consensus Estimate: $-0.31 EPS
Next Year EPS Consensus Estimate: $0.23 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.04)($0.04)($0.04)
Q2 20161($0.02)($0.02)($0.02)
Q3 20161($0.01)($0.01)($0.01)
Q4 20161($0.03)($0.03)($0.03)
Q1 20171$0.08$0.08$0.08
Q2 20171$0.06$0.06$0.06
Q3 20171$0.05$0.05$0.05
Q4 20171$0.05$0.05$0.05
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cipher Pharmaceuticals (NASDAQ:CPHR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cipher Pharmaceuticals (NASDAQ:CPHR)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Cipher Pharmaceuticals (NASDAQ:CPHR)
DateHeadline
capitalcube.com logoCipher Pharmaceuticals Ltd. :CPHR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016 (NASDAQ:CPHR)
www.capitalcube.com - August 18 at 4:23 PM
finance.yahoo.com logoCipher Pharmaceuticals Reports Q2 2016 Results Highlighted by 32% Revenue Growth and $3.1 Million Cash from Operations (NASDAQ:CPHR)
finance.yahoo.com - August 10 at 8:04 AM
finance.yahoo.com logoNotice of Cipher Pharmaceuticals Inc. Q2 2016 Conference Call (NASDAQ:CPHR)
finance.yahoo.com - July 20 at 12:00 PM
fxpips.com logoTrading Report: Manufacturing Stocks Gainers, Losers (NASDAQ:CPHR)
www.fxpips.com - July 14 at 8:31 AM
fxpips.com logoManufacturing Stocks Weekend Recap (NASDAQ:CPHR)
www.fxpips.com - July 9 at 5:59 AM
finance.yahoo.com logoSpecial Committee of Cipher Pharmaceuticals Responds to Early Warning Report Filed by 1207407 Ontario Limited (NASDAQ:CPHR)
finance.yahoo.com - July 6 at 10:00 AM
fxpips.com logoManufacturing Stocks Gainers and Losers (NASDAQ:CPHR)
www.fxpips.com - June 21 at 9:06 AM
investors.com logoEdesa Biotech licenses skin disorder treatment from Cipher (NASDAQ:CPHR)
www.proactiveinvestors.com - June 21 at 9:06 AM
finance.yahoo.com logoCipher Pharmaceuticals to Present at Two Upcoming U.S. Investor Conferences (NASDAQ:CPHR)
finance.yahoo.com - May 31 at 10:00 AM
News IconCipher Pharmaceuticals Inc. (CPHR) Broker Price Targets For The Coming Week - Share Trading News (NASDAQ:CPHR)
www.sharetrading.news - May 30 at 2:30 PM
ftsenews.co.uk logoCipher Pharmaceuticals Inc. (CPHR) Updated Price Targets - FTSE News (NASDAQ:CPHR)
www.ftsenews.co.uk - May 27 at 1:36 PM
News IconBroker Roundup For Cipher Pharmaceuticals Inc. (CPHR) - Share Trading News (NASDAQ:CPHR)
www.sharetrading.news - May 19 at 11:54 AM
fxpips.com logoPrice Advance – ATRM, CPHR, GBR, CCXI, TCX, PFNX, NVFY (NASDAQ:CPHR)
www.fxpips.com - May 19 at 11:54 AM
News IconNext Weeks Broker Price Targets For Cipher Pharmaceuticals Inc. (CPHR) - Share Trading News (NASDAQ:CPHR)
www.sharetrading.news - May 16 at 11:12 AM
capitalcube.com logoCipher Pharmaceuticals Ltd. :CPHR-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:CPHR)
www.capitalcube.com - May 11 at 11:29 AM
News IconCalgary indie pop act Lab Coast ready to deliver on all expectations (NASDAQ:CPHR)
www.theprovince.com - May 5 at 10:56 AM
News IconCipher Pharmaceuticals posts first-quarter loss of $2.7 million (NASDAQ:CPHR)
www.brandonsun.com - May 5 at 10:56 AM
streetinsider.com logoCipher Pharma (CPHR) Licenses Global Rights to Dalhousie University's Investigational Tattoo Removal Cream (NASDAQ:CPHR)
www.streetinsider.com - May 3 at 10:44 AM
streetinsider.com logoCipher Pharma (CPHR) Licenses Global Rights to Dalhousie University's Investigational Tattoo Removal Cream - StreetInsider.com (NASDAQ:CPHR)
www.streetinsider.com - May 2 at 11:37 AM
investornewswire.com logoCipher Pharmaceuticals Inc. (NASDAQ:CPHR) Has An Average Rating Of 4 - Investor Newswire (NASDAQ:CPHR)
www.investornewswire.com - April 24 at 10:28 AM
News IconAfter Last Week What Do Analysts Think Of Cipher Pharmaceuticals Inc. (CPHR) - Share Trading News (NASDAQ:CPHR)
www.sharetrading.news - April 24 at 10:28 AM
streetinsider.com logoCipher Pharma's (CPHR) CFO Norm Evans to Retire (NASDAQ:CPHR)
www.streetinsider.com - April 24 at 10:28 AM
streetinsider.com logoCipher Pharma's (CPHR) CFO Norm Evans to Retire - StreetInsider.com (NASDAQ:CPHR)
www.streetinsider.com - April 23 at 10:38 AM
News IconAnalyst Review: Cipher Pharmaceuticals Inc. (CPHR) - Risers & Fallers (NASDAQ:CPHR)
www.risersandfallers.com - April 22 at 11:30 AM
News IconAnalyst Coverage: Cipher Pharmaceuticals Inc. (CPHR) - Risers & Fallers (NASDAQ:CPHR)
www.risersandfallers.com - April 16 at 10:33 AM
clintongazette.com logoCipher Pharmaceuticals Incorporated (NASDAQ:CPHR) Shorted Shares Decreased By 0.25% - Clinton Financial (NASDAQ:CPHR)
www.clintongazette.com - April 16 at 10:33 AM
News IconCipher Pharmaceuticals Inc. (CPHR) Updated Broker Price Targets - Share Trading News (NASDAQ:CPHR)
www.sharetrading.news - April 15 at 10:51 AM
News IconCipher Pharmaceuticals Inc. (CPHR) Coverage Initiated by Analysts at TD Securities - Washington News Wire (NASDAQ:CPHR)
washingtonnewswire.com - April 13 at 10:48 AM
finance.yahoo.com logoCoverage initiated on Cipher Pharma by TD Securities (NASDAQ:CPHR)
finance.yahoo.com - April 13 at 9:07 AM
News IconCould Cipher Pharmaceuticals Inc See a Reversal After Having Formed Several Months Ascending Triangle Chart ... - Stock Caller (NASDAQ:CPHR)
www.stockcaller.com - April 12 at 10:22 AM
streetinsider.com logoCipher Pharma's (CPHR) Dermadexin and Pruridexin Approved in Canada (NASDAQ:CPHR)
www.streetinsider.com - April 7 at 10:27 AM
streetinsider.com logoCipher Pharma (CPHR) Launches Actikerall in Canada (NASDAQ:CPHR)
www.streetinsider.com - February 23 at 8:53 AM
streetinsider.com logoCipher Pharma (CPHR) Sitavig NDA Accepted for Review by Health Canada (NASDAQ:CPHR)
www.streetinsider.com - February 18 at 8:51 AM
finance.yahoo.com logo7:02 am Cipher Pharma announces review acceptance by Health Canada for Sitavig (NASDAQ:CPHR)
finance.yahoo.com - February 16 at 7:02 AM
finance.yahoo.com logoStoneCastle's Bruce Campbell Interviewed by The Life Sciences Report (NASDAQ:CPHR)
finance.yahoo.com - February 4 at 1:30 PM
finance.yahoo.com logoCipher Pharmaceuticals Inc. (CPHR) (NASDAQ:CPHR)
finance.yahoo.com - January 23 at 5:22 PM
finance.yahoo.com logoEuro Pacific Canada's Doug Loe Interviewed by The Life Sciences Report (NASDAQ:CPHR)
finance.yahoo.com - January 15 at 9:00 AM
finance.yahoo.com logoSanta Brings FDA and Health Canada Approvals for New Dermatology Products (NASDAQ:CPHR)
finance.yahoo.com - December 21 at 9:45 AM
finance.yahoo.com logoNotice of Cipher Pharmaceuticals Inc. Q3 2015 Conference Call (NASDAQ:CPHR)
finance.yahoo.com - October 21 at 8:30 AM
finance.yahoo.com logoCipher announces settlement in patent litigation for Absorica® (NASDAQ:CPHR)
finance.yahoo.com - October 5 at 7:00 AM
finance.yahoo.com logoCPHR: Product Sales Picked Up Steam in Second Quarter of 2015 (NASDAQ:CPHR)
finance.yahoo.com - August 21 at 11:25 AM

Social

Cipher Pharmaceuticals (NASDAQ:CPHR) Chart for Saturday, August, 27, 2016


Last Updated on 8/27/2016 by MarketBeat.com Staff